Diflucan® Birth Defect Claims
The U.S. Food and Drug Administration (FDA) issued a public safety announcement, Aug. 3, 2011, to notify health care providers and consumers about an increased risk of birth defects in babies whose mothers took 400-800 mg of Diflucan® (fluconazole)/day during all or most of their pregnancies.
The FDA said it based its findings on case reports in which babies were born with various birth defects, including congenital heart disease, abnormal face defects and bowing of the thigh bones after being exposed to high doses of Diflucan® during fetal development.
The agency changed the drug’s pregnancy category from C to D. The agency noted that the warning does not affect the single dose (150 mg).
If you were prescribed Diflucan® during your pregnancy and your baby is born with a congenital defect, you may be entitled to compensation. To learn more, schedule a free case review with a qualified, professional and compassionate Diflucan® birth defect lawyer today.
Diflucan® (fluconazole) is an antibiotic that is prescribed for the treatment of various types of yeast infections such as those of... read more
Diflucan® (fluconazole) has been associated with birth defects in babies whose mothers take a high dose of the medication for most... read more
The U.S. Food and Drug Administration (FDA) issued a safety communication on Aug. 3, 2011 to alert patients and health care... read more